Research Article

Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China

Table 2

Relationship between SDC1 immunoreactivity and clinicopathological characteristics, 477 CRC cases.

Clinical informationTotalSDC1L

Case (%)
SDC1M

Case (%)
SDC1H

Case (%)

Age, yr
<60.521167 (32)93 (44)51 (24)2.130.345
>60.526673 (27)135 (51)58 (22)
Gender
Female22769 (30)110 (49)48 (21)0.7520.686
Male25071 (28)118 (47)61 (24)
Tumor size, cm
≤430692 (30)138 (45)76 (25)2.9240.232
>417148 (28)90 (53)33 (19)
Histological grade (differentiation) (miss samples, )
Well22675 (33)111 (49)40 (18)8.120.017
Moderately or poorly23559 (25)110 (47)66 (28)
TNM stage (T)
1-26914 (20)22 (32)33 (48)28.55≤0.001
3-4408126 (31)206 (50)76 (19)
Lymph node metastasis
N029066 (23)140 (48)84 (29)23.088≤0.001
N1-318774 (40)88 (47)25 (13)
Location (miss samples, )
Left4917 (35)23 (47)9 (18)1.1230.570
Right14238 (27)74 (52)30 (21)

L: low expression; M: moderate expression; H: high expression; statistical method: chi-square test.